News

Recent weeks have been ripe with deals among artificial intelligence (AI) players. Words from Nvidia's (NASDAQ: NVDA) Jensen Huang during the company's earnings report in August set the stage for

The S&P 500 (SNPINDEX: ^GSPC) is having a great year, led by strong gains in tech, communications, financials, and industrials. But not every sector is performing well.

The consumer staples sector

Obesity drugs are arguably the hottest growth opportunity in the healthcare sector.

These drugs primarily work by slowing digestion and suppressing patients' appetites. What began as a treatment for

The stock market has continued to rise this year, with the S&P 500 up over 13%. That has it trading at more than 20 times earnings, well above its average in the mid-teens over the past

Shares of SoFi Technologies (NASDAQ: SOFI) have been on an unbelievable run. During the past year, they have soared 166% (as of Oct. 17). The tech heavy Nasdaq Composite is up 24% during the same

Opendoor Technologies (NASDAQ: OPEN) runs one of the biggest real estate direct buying operations in the U.S., which involves purchasing homes from willing sellers and attempting to flip them for a

If you are looking to create a portfolio that can provide you with a lifetime of passive income, then you need to look closely at exchange-traded funds (ETFs). They are simple to buy and sell and

If you're still working and tucking money into a retirement plan, you're in the "accumulation" phase. Once retired, you've officially entered the "decumulation" phase, the period of life during

The Oct. 10 flash crash clarified a lot about crypto, and the picture it painted for XRP (CRYPTO: XRP) and Ripple's U.S. dollar stablecoin, RLUSD (CRYPTO: RLUSD), could be more encouraging than the

Legendary investor Warren Buffett proved that so-called "boring" stocks can produce huge gains over long periods of time. Often, these businesses don't make the headlines for months at a time, or

Recently, all three of Wall Street's major stock indexes climbed to fresh record-closing highs. The primary catalyst fueling these gains is investor optimism tied to game-changing technological

"Social Security is going bankrupt." "Congress is stealing money from Social Security." "Social Security is nothing but a giant Ponzi scheme."

These are some of the things you might hear about

With roughly 10 weeks to go before 2025 comes to a close, it looks as if it'll be another banner year on Wall Street -- and the evolution of artificial intelligence (AI) is a big reason why.

Every investor has whispered the same question at least once: What if I had bought that quirky thing before everyone else cared about it? Sometimes that thought experiment is just entertainment

With shares up by a jaw-dropping 5,100% over the last 12 months, Rigetti Computing (NASDAQ: RGTI) exemplifies the life-changing potential of stock investing. If you bought $10,000 worth of shares of

When investors think about artificial intelligence (AI) hardware stocks, Nvidia understandably dominates the conversation. Yet beneath the surface, another semiconductor powerhouse is making

The American dream is something like owning your own home, living comfortably, and seeing your children live happy and productive lives. That dream is even better if you can pass on your wealth to

Investing in top consumer brands that pay reliable dividends can be more rewarding than some investors realize. For example, Hartford Funds found that 85% of the S&P 500's return since 1960 would

Nvidia (NASDAQ: NVDA) has been one of the most successful stocks in the artificial intelligence (AI) arms race, rising 1,130% since it began at the start of 2023. This has delivered long-term

According to a filing with the Securities and Exchange Commission dated October 17, 2025, investment management company Capricorn Fund Managers Ltd established a new position in Waystar (NASDAQ:WAY)

Florida-based wealth advisory J. L. Bainbridge disclosed a purchase of Eli Lilly and Company valued at approximately $45.6 million for the quarter ended September 30, according to an SEC filing

Florida-based wealth advisory J. L. Bainbridge & Co. sold 119,376 shares of Biogen (NASDAQ:BIIB) during the third quarter for an estimated $16.1 million.

In a quarterly disclosure filed with the